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Use of Optical Coherence Tomography (OCT) for Characterization of Carotid
Plaque In Patients with Severe Asymptomatic Carotid Stenosis
Mehmet Cilingiroglu1, Mark Wholey1
1UPMC Heart and Vascular Institute, Pittsburgh, PA
Background: Carotid artery related stroke is mainly an embolic disease that has been
associated with inflammation, plaque rupture, and thrombus formation in vulnerable
atherosclerotic plaque. Almost, two-thirds of these strokes affect patients who are
previously asymptomatic. Estimation of the degree of stenosis in a carotid lesion based on
angiography is a poor predictor of clinical outcome. We propose that stroke risk may be
best predicted by plaque morphology in these asymptomatic lesions using OCT with its
unique fine imaging resolution.
Methods: We have performed OCT imaging of carotid plaques in 22 consecutive
asymptomatic patients with severe carotid artery stenosis. Detailed analysis showed
various features of high-risk vulnerable plaque such as thin-cap fibroatheroma, plaque
rupture, intraluminal thrombus, calcifications in some (n13) while the remaining had
none of these features (n9). Periprocedural events rates were compared between two
groups.
Results: Patients with high-risk vulnerable plaque features had more periprocedural
events, while the patients without these features had no events.
Conclusions: OCT can be used safely and effectively to identify high-risk vulnerable
plaque features in asymptomatic patients with severe carotid artery stenosis for further risk
stratification and optimal treatment strategy such as carotid artery stenting versus carotid
endarderectomy.
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Vaisseaux, RABAT, Morocco, 3Cabinet de cardiologie, nancy, France
Background: To evaluate the safety and efficiency of vertebral angioplasty and stenting
(VAS) in symptomatic patients.
Methods: Material and Methods: 102 angioplasties in 96 pts (M:72) mean age 68,3 6,7
years (22-84) left 58. All pts had multivascular diseases: carotid (CA):63, subclavian
(SA): 26, coronary:64. . . . Atheromatous lesions: 100, inflammatory: 2. Mean lesion
length: 9,6	/ 2,8 mm. Mean % stenosis 83.2 7.7, mean arterial diameter : 4,8 0,6
mm (4-6). 94 lesions at VO segment (ostium), 6 at V1 and 2 at V2 segments. Indications
for angioplasty: dizziness (96), bilateral weakness (11), visual changes (11), diplopia (10),
drop attacks (20), TIA (13), ataxia (5). A protection device (filter) used in 10 pts. 20 SA
angioplasties performed at the same time of VAS, 8 CA. All angioplasties performed by
femoral approach, 4 by brachial approaches after failure of femoral approach. (2
successes).
Results: Technical success 100/102 (98%). 6 lesions treated by angioplasty alone: 3 VO
(first 3 pts. 2 V1, 1 V2 lesion). 1 pt (inflammatory disease) treated by cutting balloon
alone. 93 lesions treated with stents (direct stenting: 78). Peripheral balloon expandable
stents (n23), self expandable stents (n4 for 3 V1 and one V2 lesions). 70 coronary
stents (14 DES). 1 pt developed a TIA during the procedure. No neurological complica-
tions at 30 days Clinical success 94/96 (98%) Post-procedure arterial diameter: 4,55 0,8
mm (4-6). Mean residual stenosis 2,2  3,5 %. In 10 pts treated with protection devices,
visible debris removed in 7 (5 Filterwire, 2 Fibernet) with the same amount of debris as
during Carotid Stenting) 7 pts (8%) developed a symptomatic restenosis during the
follow-up (mean: 31.4.28.9 months), 3 after PTA alone, 4 after PTA and stent (1
occlusion treated medically, 6 stenoses successfully treated with PTA). No restenosis after
DES implantation at 1 year.
Conclusions: VAS can be performed safely and effectively with a high technical success
rate, a low complication rate, a low restenosis rate and a durable clinical success in
patients with symptomatic VA stenosis. Stents seem to improve immediate and long-term
results. The role of protection devices and D.E.S has to be discussed.
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Background: It is now clear that atheroemboli are the rule in any intervention in
atherosclerotic disease and seems the root cause of many procedural complications.
Embolic protection devices (EPD) reduce the number of cerebral emboli during carotid
angioplasty stenting (CAS).Recent studies have shown a high incidence of emboli during
Vertebral Angioplasty Stenting (V.A.S) and a comparable frequency and amount of
captured emboli during V.A.S and CAS. Neurological complications after V.A.S are not
frequent but could be devastating. So the use of EPD for VAS may be advisable and
should reduce the neurological complications during V.A.S
Methods: We retrospectively determined rates of technical success and one month stroke
and death associated with stent placement by using EPD (Filterwire and Fibernet filter in
patients with symptomatic ostial VA stenoses. Technical success was defined as
successful EPD deployment and stent placement, successful EPD retrieval and a residual
stenosis 30%. 30 day outcomes included any stroke and death. The new EPD (Fibernet)
allows capture of debris of 40 microns without compromising the flow. Its retrieval
catheter is an aspiration catheter allowing meticulous cleaning of the vessel and of the
dilated area
Results: In a series of 102 VAS, 10 patients treated with EPD. Mean age 69 y. (63-80).
Male: 8, left 6. Mean % stenosis 80,96,8. Mean arterial diameter: 4,8  0,5mm.
Femoral approach used in all cases. Filterwire :8 patients, Fibernet: 2. Technical success
was achieved for the 10 patients. Postprocedure residual stenoses: 43%. Visible debris
were removed in 70% of cases (Filterwire:5 and Fibernet:2). Filter deployment time: 10
mm (7-13 mm). No stroke or death observed at one month. With Fibernet mean debris
area: 184 mm2. (aspirated debris : 114mm2, debris in the filter 70 mm2) Debris analysis
will be reported. These results are comparable to the results obtained in CAS.
Conclusions: The present study demonstrates the feasibility and safety of VAS using
EPD. Further studies are required to determine the exact role of EPD and their indications
in VAS. It seems that the results obtained in VAS are comparable to those obtained after
CAS.
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Background: In-stent restenosis (ISR) after carotid artery stenting (CAS) is a rare event.
Endovascular treatment is considered for significant ISR (80% diameter stenosis by
Doppler US). Despite favorable acute results, recurrent ISR ranges between 0 and 50%.
Evidence of DEB effectiveness for coronary and peripheral ISR treatment is accumulat-
ing. We assessed the safety and efficacy of DEB in ISR after CAS.
Methods: Significant ISR occurred in 11/803 (1.3%) consecutive CAS procedures at a
median F/U of 624580 days. In 7 pts (6 internal and 1 common carotid arteries), DEB
(In.Pact Admiral,Invatec-Medtronic,Italy) treatment (single 3-minute inflation) was per-
formed after standard predilation with distal cerebral protection. DEB size was selected by
IVUS (1:1 stent to DEB size ratio). Post-DEB, patients were treated with double
antiplatelet therapy for 3 months. Acute and long-term clinical outcomes were obtained in
all pts.
Results: Technical and procedural success was 100%. Angiographic stenosis decreased
from 835% to 186%. Minimal lumen area by IVUS increased from 3.21.8 to
12.62.1mm2 (p0.001), stent area was unchanged (from 17.54.7 to 17.34.7mm2)
and restenosis area decreased from 13.65.8 to 4.63.3mm2 (p0.001). At a F/U of
41252 days (range 343-455), no clinical event occurred. Average Doppler Peak Systolic
TUESDAY, OCTOBER 23, 8:00 AM–10:00 AM www.jacc.tctabstracts2012.com
B56 JACC Vol 60/17/Suppl B | October 22–26, 2012 | TCT Abstracts/POSTER/Carotid and Neurovascular Disease and Intervention
P
O
ST
E
R
S
